BSE Live
Oct 08, 10:33Prev. Close
12.76
Open Price
12.84
Bid Price (Qty.)
12.41 (330)
Offer Price (Qty.)
12.47 (384)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Balance Sheet of Gennex Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 22.74 | 22.74 | 18.02 | 12.65 | 12.65 | |
Total Share Capital | 22.74 | 22.74 | 18.02 | 12.65 | 12.65 | |
Reserves and Surplus | 163.94 | 141.92 | 62.33 | 31.16 | 27.06 | |
Total Reserves and Surplus | 163.94 | 141.92 | 62.33 | 31.16 | 27.06 | |
Total Shareholders Funds | 186.69 | 170.38 | 80.35 | 43.82 | 39.71 | |
Minority Interest | 7.90 | 6.08 | 6.17 | 0.00 | 0.00 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | |
Other Long Term Liabilities | 16.89 | 13.22 | 16.29 | 0.00 | 0.00 | |
Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 16.89 | 13.22 | 16.29 | 0.00 | 0.15 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 10.22 | 5.72 | 1.05 | 10.12 | 7.36 | |
Trade Payables | 13.16 | 15.18 | 7.08 | 7.74 | 5.94 | |
Other Current Liabilities | 20.58 | 18.95 | 20.77 | 5.71 | 5.18 | |
Short Term Provisions | 0.59 | 0.45 | 0.61 | 0.63 | 0.56 | |
Total Current Liabilities | 44.55 | 40.30 | 29.51 | 24.21 | 19.04 | |
Total Capital And Liabilities | 256.04 | 229.99 | 132.32 | 68.03 | 58.90 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 56.62 | 52.70 | 76.71 | 13.70 | 14.13 | |
Intangible Assets | 2.94 | 2.94 | 6.11 | 0.00 | 0.00 | |
Capital Work-In-Progress | 5.22 | 2.32 | 0.02 | 0.00 | 0.00 | |
Fixed Assets | 64.78 | 57.96 | 82.84 | 13.70 | 14.13 | |
Non-Current Investments | 0.00 | 0.01 | 0.01 | 6.83 | 6.83 | |
Deferred Tax Assets [Net] | 0.18 | 0.23 | 0.14 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 9.95 | 9.97 | 0.65 | 0.32 | 0.28 | |
Total Non-Current Assets | 74.91 | 68.17 | 83.63 | 20.84 | 21.23 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 35.94 | 25.17 | 15.69 | 7.74 | 5.02 | |
Trade Receivables | 14.16 | 17.81 | 9.42 | 11.31 | 8.95 | |
Cash And Cash Equivalents | 55.57 | 60.97 | 15.06 | 8.31 | 1.07 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 75.46 | 57.85 | 8.51 | 19.82 | 22.63 | |
Total Current Assets | 181.13 | 161.81 | 48.68 | 47.18 | 37.67 | |
Total Assets | 256.04 | 229.99 | 132.32 | 68.03 | 58.90 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 0.98 | 0.74 | 0.74 | 1.70 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Non-Current Investments Unquoted Book Value | 0.00 | 0.01 | 0.01 | 6.83 | 6.83 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
11.06.2025
Gennex Labs Standalone March 2025 Net Sales at Rs 23.28 crore, up 9.14% Y-o-Y
03.06.2025
Gennex Labs Consolidated March 2025 Net Sales at Rs 40.33 crore, up 20.36% Y-o-Y
04.03.2025
Gennex Labs Consolidated December 2024 Net Sales at Rs 40.01 crore, up 108.98% Y-o-Y
28.11.2024
Gennex Labs Consolidated September 2024 Net Sales at Rs 31.55 crore, up 79.46% Y-o-Y
11.06.2025
Gennex Labs Standalone March 2025 Net Sales at Rs 23.28 crore, up 9.14% Y-o-Y
03.06.2025
Gennex Labs Consolidated March 2025 Net Sales at Rs 40.33 crore, up 20.36% Y-o-Y
04.03.2025
Gennex Labs Consolidated December 2024 Net Sales at Rs 40.01 crore, up 108.98% Y-o-Y
28.11.2024
Gennex Labs Consolidated September 2024 Net Sales at Rs 31.55 crore, up 79.46% Y-o-Y